Cryo-Cell International Inc
cryo-cell.comCryo-Cell International (CCEL) is a cord blood and cord tissue banking company that collects, processes, and stores newborn stem cells for potential future medical use. The company makes money by charging families an upfront processing fee at the time of collection and recurring annual storage fees for the ongoing preservation of the biological material. The filing excerpts from the 10-K filed 2026-02-27 covering fiscal year ended November 30, 2025 identify the company as Cryo-Cell International, Inc. The business operates under a subscription-like storage model, where the recurring storage fee component provides a base of contractual, long-term revenue tied to the number of specimens under management. Switching costs are meaningful once a family has enrolled, as transferring stored biological samples is logistically complex and emotionally sensitive.
Products & Services
Cord blood banking, cord tissue banking, newborn stem cell processing and long-term cryogenic storage. Specific product names or additional service lines are not supported by the provided excerpts.
Revenue Model
The filing excerpts reference revenue recognition as a noted accounting topic for fiscal years ended November 30, 2025 and 2024, consistent with a dual-stream model of one-time enrollment and processing fees plus recurring annual storage fees. Specific revenue figures are not supported by the provided excerpts.
Customers & Markets
Expectant families seeking to preserve newborn cord blood and cord tissue stem cells for potential future medical or therapeutic use. Specific customer counts or end-market data are not supported by the provided excerpts.
Geographic Exposure
The company is identified as a U.S.-registered entity filing with the SEC. Specific geographic revenue breakdown or international operations are not supported by the provided excerpts.
Financial Snapshot
Loading...
